H Neda

1.6k total citations
45 papers, 1.3k citations indexed

About

H Neda is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, H Neda has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Immunology and 8 papers in Oncology. Recurrent topics in H Neda's work include RNA Interference and Gene Delivery (12 papers), Immune Response and Inflammation (11 papers) and Immunotherapy and Immune Responses (9 papers). H Neda is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Immune Response and Inflammation (11 papers) and Immunotherapy and Immune Responses (9 papers). H Neda collaborates with scholars based in Japan and United States. H Neda's co-authors include Naofumi Yamauchi, Masahiro Maeda, Hiroshi Kuriyama, I Urushizaki, Yoshiro Niitsu, Naoki Watanabe, Naoki Watanabe, Hiroshi Umeno, Yoshiro Niitsu and Naoki Watanabe and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Annals of the New York Academy of Sciences.

In The Last Decade

H Neda

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Neda Japan 18 756 513 273 213 163 45 1.3k
Naofumi Yamauchi Japan 23 925 1.2× 555 1.1× 248 0.9× 280 1.3× 193 1.2× 63 1.7k
I Urushizaki Japan 20 698 0.9× 408 0.8× 125 0.5× 267 1.3× 142 0.9× 91 1.6k
James R. Zucali United States 19 593 0.8× 447 0.9× 174 0.6× 470 2.2× 263 1.6× 42 1.5k
Masayuki Tsuchiya Japan 23 869 1.1× 626 1.2× 90 0.3× 341 1.6× 253 1.6× 39 1.9k
TR Bradley Australia 11 615 0.8× 807 1.6× 254 0.9× 588 2.8× 92 0.6× 18 2.2k
ML Sherman United States 14 878 1.2× 298 0.6× 115 0.4× 335 1.6× 338 2.1× 26 1.5k
G. H. Heppner United States 22 690 0.9× 605 1.2× 240 0.9× 845 4.0× 465 2.9× 47 1.8k
George H. Mickey United States 9 709 0.9× 274 0.5× 217 0.8× 377 1.8× 249 1.5× 11 1.5k
C. Rosenfeld France 17 579 0.8× 257 0.5× 84 0.3× 197 0.9× 86 0.5× 64 1.2k
NN Tandon United States 10 497 0.7× 349 0.7× 120 0.4× 129 0.6× 131 0.8× 15 1.3k

Countries citing papers authored by H Neda

Since Specialization
Citations

This map shows the geographic impact of H Neda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Neda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Neda more than expected).

Fields of papers citing papers by H Neda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Neda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Neda. The network helps show where H Neda may publish in the future.

Co-authorship network of co-authors of H Neda

This figure shows the co-authorship network connecting the top 25 collaborators of H Neda. A scholar is included among the top collaborators of H Neda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Neda. H Neda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neda, H, Manabu Maeda, Takuya Fujita, et al.. (2001). [A case of retroperitoneal malignant fibrous histiocytoma with marked response to cisplatin, ifosfamide and doxorubicin].. PubMed. 28(6). 849–53. 2 indexed citations
2.
Lu, Yue, Shigeyuki Fujii, H Neda, et al.. (1995). Efficacy of tnf‐α gene‐transduced tumor cells in treatment of established in vivo tumor. International Journal of Cancer. 63(1). 130–135. 20 indexed citations
3.
Watanabe, Naoki, Naofumi Yamauchi, Masahiro Maeda, et al.. (1994). Recombinant Human Tumor Necrosis Factor Causes Regression in Patients with Advanced Malignancies. Oncology. 51(4). 360–365. 17 indexed citations
4.
5.
Fujii, Shigeyuki, Yingxian Liu, H Neda, et al.. (1994). Augmented Systemic Immunity in Mice Implanted with Tumor Necrosis Factor‐α Gene‐transduced Meth‐A Cells. Japanese Journal of Cancer Research. 85(3). 315–324. 8 indexed citations
6.
Fujii, Shigeyuki, H Neda, Minoru Takahashi, et al.. (1994). Mechanisms of Tumor Regression of TNF Gene‐Transduced Meth‐A Cells Transplanted in Mice. Annals of the New York Academy of Sciences. 716(1). 334–335. 2 indexed citations
7.
Kohgo, Yutaka, Junji Kato, & H Neda. (1993). Targeting cancer therapy by transferrin receptor mediated endocytosis.. Drug Delivery System. 8(2). 91–95. 1 indexed citations
8.
Maeda, Masahiro, Naoki Watanabe, H Neda, et al.. (1992). Serum Tumor Necrosis Factor Activity in Inflammatory Bowel Disease. Immunopharmacology and Immunotoxicology. 14(3). 451–461. 67 indexed citations
9.
Watanabe, Naoki, Naofumi Yamauchi, H Neda, et al.. (1992). Enhancement of Lysosomal Enzyme Activity by Recombinant Human Tumor Necrosis Factor and Its Role in Tumor Cell Killing in vitro. Japanese Journal of Cancer Research. 83(6). 638–643. 1 indexed citations
10.
Neda, H, Catherine H. Wu, & George Y. Wu. (1991). Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. Journal of Biological Chemistry. 266(22). 14143–14146. 65 indexed citations
11.
Yamauchi, Naofumi, Naoki Watanabe, Hiroshi Kuriyama, et al.. (1990). Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factor. International Journal of Cancer. 46(5). 884–888. 61 indexed citations
12.
Himeno, Tatsuhito, Naoki Watanabe, Naofumi Yamauchi, et al.. (1990). Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor.. PubMed. 50(16). 4941–5. 51 indexed citations
13.
Watanabe, Naoki, H Neda, Naofumi Yamauchi, et al.. (1989). Signalling pathway of tumor necrosis factor in normal and tumor cells. Cancer Immunology Immunotherapy. 28(3). 157–63. 23 indexed citations
14.
Watanabe, Naoki, Yoshiro Niitsu, Naofumi Yamauchi, et al.. (1988). Synergistic Cytotoxicity of Recombinant Human TNF and Various Anti-Cancer Drugs. Immunopharmacology and Immunotoxicology. 10(1). 117–127. 22 indexed citations
15.
Watanabe, Naoki, Yoshiro Niitsu, Naofumi Yamauchi, et al.. (1988). Therapeutic Effect of Ok-432 Induced Endogenous Tnf on Tumor Bearing Mice and Cancer Patients. Immunopharmacology and Immunotoxicology. 10(1). 53–65. 6 indexed citations
16.
Watanabe, Naoki, Yoshiro Niitsu, H Neda, et al.. (1988). Cytotocidal Mechanism of TNF: Effects of Lysosomal Enzyme and Hydroxyl Radical Inhibitors on Cytotoxicity. Immunopharmacology and Immunotoxicology. 10(1). 109–116. 24 indexed citations
17.
Watanabe, Naoki, Y Niitsu, Naofumi Yamauchi, et al.. (1987). Cell cycle specificity of tumor necrosis factor and its receptor. Cell Biology International Reports. 11(11). 813–817. 8 indexed citations
18.
Watanabe, Norihiro, Hiroshi Umeno, H Neda, et al.. (1987). [The synergistic effect of human recombinant TNF in combination with hyperthermia].. PubMed. 22(3). 632–7. 1 indexed citations
19.
Watanabe, Naoki, et al.. (1984). [Mechanisms of production of tumor necrosis factor (TNF)--reconstitution experiment white nude mice].. PubMed. 11(6). 1284–9. 1 indexed citations
20.
Watanabe, Naoki, et al.. (1984). [Anti-metastatic effect of tumor necrosis factor (TNF)].. PubMed. 19(5). 1049–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naofumi Yamauchi Breakdown of academic impact, for papers by I Urushizaki Breakdown of academic impact, for papers by James R. Zucali Breakdown of academic impact, for papers by Masayuki Tsuchiya Breakdown of academic impact, for papers by TR Bradley Breakdown of academic impact, for papers by ML Sherman Breakdown of academic impact, for papers by G. H. Heppner Breakdown of academic impact, for papers by George H. Mickey Breakdown of academic impact, for papers by C. Rosenfeld Breakdown of academic impact, for papers by NN Tandon
Rankless by CCL
2026